AMAG Pharmaceuticals Stock News

AMAG Pharmaceuticals, Inc. (AMAG) today announced that management will participate at the Jefferies Virtual Global Healthcare Conference on Wednesday, June 3, 2020 at 4:00 p.m. Eastern Time. A live

As the nation started to reopen this week following two months of closed businesses and stay-at-home orders, public health officials and economists

AMAG Pharmaceuticals wants out of the women’s health business---and now it’s halfway there. On Thursday the Waltham, MA-based biotech said it had found a

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 21) ADC Therapeutics SA (NYSE:...

AMAG Pharmaceuticals, Inc. (AMAG) today announced it has completed the sale of its rights to Intrarosa® (prasterone) to Millicent Pharma Limited, a global pharmaceutical company formed by the Millic

Final earnings conference call transcript of Antares Pharma Inc. - ATRS stock

Zuora Inc. (NYSE:ZUO), der führende Anbieter Cloud-basierter Subscription-Management-Plattformen, gab heute bekannt, dass der Mobilitätsdienst der Mar

This was a disappointing week for at least two major drug makers. French firm Genfit reported a trial failure in an intensely competitive indication, and

Apart from the impact of the COVID-19 pandemic, the main topic that was tossed around in Palatin Technologies' (NYSE: PTN) third quarter earnings call was related to AMAG Pharmaceuticals' divestiture

AMAG Pharmaceuticals' (AMAG) loss narrows year over year while sales top estimates in the first quarter of 2020. The company scraps 2020 outlook due to the plaguing pandemic effect.